Organization · Private Equity
Biospring Partners
Biospring Partners is a growth buyout firm based in New York, specializing in technology-enabled investments in the pharma services sector. They focus on B2B services and tools that enhance innovation in life sciences.
Overview
What Biospring Partners does
What Biospring Partners is
Biospring Partners is a growth buyout firm based in New York, specializing in technology-enabled investments in the pharma services sector. They focus on B2B services and tools that enhance innovation in life sciences.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Biospring Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Biospring Partners as a funder
Investment thesis
Biospring Partners invests in technology-enabled, EBITDA-positive B2B pharma services businesses, particularly in outsourced complex biomanufacturing and clinical trial services.
Focus narrative
Biospring Partners targets investments in outsourced complex biomanufacturing, outsourced clinical trial services, and digital transformation. They seek to back companies that are modernizing clinical trials and improving site operations through technology.
Focus and fit
- Regions
- North America
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Biospring Partners' portfolio includes companies engaged in clinical trials, complex biomanufacturing, and digital transformation. Notable areas of investment include outsourced biologics manufacturing, clinical trial site networks, digitized pathology platforms, outsourced cell therapy manufacturing, lab procurement platforms, and direct-to-patient platforms for clinical trials.
Common questions
What to know about Biospring Partners
Upseed classifies Biospring Partners under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.